PATIENTS taking blockbuster diabetes and weight loss drugs are waking up with vision loss, researchers warn. Some reported ...
Ozempic and Wegovy maker Novo Nordisk placed a print ad responding to the Super Bowl spot from competitor Hims & Hers.
Novo Nordisk boasts 45 million customers using their drug Ozempic, which has caused a revolution in weight-loss treatment.
The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both ...
Medical experts have raised concerns over popular weight loss drugs like Ozempic and Mounjaro after emerging evidence found ...
18h
Stockhead on MSNOzempic’s PBS push could shake up ASX food stocks, and here’s howBig pharma’s pushing for PBS funding, and it’s kickstarting a shift to healthier snacks, smaller portions and more booze-free ...
3h
Axios Vitals on MSNWegovy and Ozempic stars dim amid overuse concernsThe luster is starting to wear off GLP-1 weight-loss drugs including Wegovy and Ozempic as more clinicians warn patients ...
Experts from five states have sounded the alarm about blockbuster weight loss drugs like Ozempic leaving users blind, ...
Debate over childhood obesity treatments: weight-loss drugs vs. lifestyle changes, with concerns about long-term effects.
Ozempic and Wegovy maker Novo Nordisk placed a print ad responding to the Super Bowl spot from competitor Hims & Hers.
The grants have been the source of new treatments for cancer, heart disease, diabetes, strokes and H.I.V.; wonder drugs like ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results